Displaying 1 - 2 of 2
| Active Ingredient | FENOFIBRATE |
| Therapeutic Class | FIBRIC ACID DERIVATIVES |
| Indications |
Used to reduce low-density lipoprotein (LDL)-cholesterol, total cholesterol, triglycerides, and apolipop rotein B, and to increase high-density lipoprotein (HDL)-cholesterol, in the management of Hy More ... |
| Caution | Liver function test should be carried out every 3 months.Serious muscle toxicity, including myopathy and rhabdomyolysis, has been reported in patients receiving fibric acid derivatives. Risk appears t More ... |
| Dose Range |
Adult: 67 mg three times daily or 200 mg once daily . Pediatric (4-15 years): 1 cap sule/20mg daily . |
| Drug Interactions | |
| Pregnancy | Fenofibrate is not recommended during pregnancy. |
| Breast Feeding | Fenofibrate is not recommended for lactating women. |
| Active Ingredient | GEMFIBROZIL |
| Therapeutic Class | FIBRIC ACID DERIVATIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |